{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:41:26Z","timestamp":1787060486326,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15124-6","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:01:28Z","timestamp":1763737288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepcidin as an emerging predictor biomarker of leptomeningeal metastases in patients with metastatic breast cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Constance","family":"Delaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Al Herk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Laigre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pouderoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pradeilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Darlix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"15124_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0055-y","volume":"5","author":"AS Achrol","year":"2019","unstructured":"Achrol AS, Rennert RC, Anders C, Soffietti R, Ahluwalia MS, Nayak L, et al. Brain metastases. Nat Rev Dis Primers. 2019;5:5. https:\/\/doi.org\/10.1038\/s41572-018-0055-y.","journal-title":"Nat Rev Dis Primers"},{"key":"15124_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.18632\/oncotarget.27453","volume":"11","author":"L Koniali","year":"2020","unstructured":"Koniali L, Hadjisavvas A, Constantinidou A, Christodoulou K, Christou Y, Demetriou C, et al. Risk factors for breast cancer brain metastases: a systematic review. Oncotarget. 2020;11:650\u201369. https:\/\/doi.org\/10.18632\/oncotarget.27453.","journal-title":"Oncotarget"},{"key":"15124_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12885-019-5287-z","volume":"19","author":"A Darlix","year":"2019","unstructured":"Darlix A, Hirtz C, Thezenas S, Maceski A, Gabelle A, Lopez-Crapez E, et al. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases. BMC Cancer. 2019;19:110. https:\/\/doi.org\/10.1186\/s12885-019-5287-z.","journal-title":"BMC Cancer"},{"key":"15124_CR4","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/ijc.30290","volume":"139","author":"A Darlix","year":"2016","unstructured":"Darlix A, Lamy P-J, Lopez-Crapez E, Braccini AL, Firmin N, Romieu G, et al. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases? Int J Cancer. 2016;139:2299\u2013311. https:\/\/doi.org\/10.1002\/ijc.30290.","journal-title":"Int J Cancer"},{"key":"15124_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/ijc.33724","volume":"149","author":"A Darlix","year":"2021","unstructured":"Darlix A, Hirtz C, Mollevi C, Ginestet N, Tiers L, Jacot W, et al. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer. Int J Cancer. 2021;149:1605\u201318. https:\/\/doi.org\/10.1002\/ijc.33724.","journal-title":"Int J Cancer"},{"issue":"suppl_4","key":"15124_CR6","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, et al. EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol. 2017;28(suppl_4):iv84-99. https:\/\/doi.org\/10.1093\/annonc\/mdx221.","journal-title":"Ann Oncol."},{"key":"15124_CR7","doi-asserted-by":"publisher","first-page":"101624","DOI":"10.1016\/j.esmoop.2023.101624","volume":"8","author":"E Le Rhun","year":"2023","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rud\u00e0 R, et al. Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2023;8:101624. https:\/\/doi.org\/10.1016\/j.esmoop.2023.101624.","journal-title":"ESMO Open"},{"key":"15124_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/neuonc\/noz012","volume":"21","author":"A Boire","year":"2019","unstructured":"Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junck L, et al. Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro Oncol. 2019;21:571\u201384. https:\/\/doi.org\/10.1093\/neuonc\/noz012.","journal-title":"Neuro Oncol"},{"key":"15124_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/clinchem\/hvac127","volume":"68","author":"A Darlix","year":"2022","unstructured":"Darlix A, Cayrefourcq L, Pouderoux S, Menjot de Champfleur N, Bievelez A, Jacot W, et al. Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study. Clin Chem. 2022;68:1311\u201322. https:\/\/doi.org\/10.1093\/clinchem\/hvac127.","journal-title":"Clin Chem."},{"key":"15124_CR10","doi-asserted-by":"publisher","first-page":"1034684","DOI":"10.3389\/fnagi.2022.1034684","volume":"14","author":"C Delaby","year":"2022","unstructured":"Delaby C, Bousiges O, Bouvier D, Fill\u00e9e C, Fourier A, Mond\u00e9sert E, et al. Neurofilaments contribution in clinic: state of the art. Front Aging Neurosci. 2022;14:1034684. https:\/\/doi.org\/10.3389\/fnagi.2022.1034684.","journal-title":"Front Aging Neurosci"},{"key":"15124_CR11","doi-asserted-by":"publisher","first-page":"102340","DOI":"10.1016\/j.ceb.2024.102340","volume":"87","author":"AJEM de Reus","year":"2024","unstructured":"de Reus AJEM, Basak O, Dykstra W, van Asperen JV, van Bodegraven EJ, Hol EM. GFAP-isoforms in the nervous system: understanding the need for diversity. Curr Opin Cell Biol. 2024;87:102340. https:\/\/doi.org\/10.1016\/j.ceb.2024.102340.","journal-title":"Curr Opin Cell Biol"},{"key":"15124_CR12","doi-asserted-by":"publisher","first-page":"175909142094968","DOI":"10.1177\/1759091420949680","volume":"12","author":"A Messing","year":"2020","unstructured":"Messing A, Brenner M. GFAP at 50. ASN Neuro. 2020;12:1759091420949680. https:\/\/doi.org\/10.1177\/1759091420949680.","journal-title":"ASN Neuro"},{"key":"15124_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0165-0173(00)00019-9","volume":"33","author":"L Bu\u00e9e","year":"2000","unstructured":"Bu\u00e9e L, Bussi\u00e8re T, Bu\u00e9e-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev. 2000;33:95\u2013130. https:\/\/doi.org\/10.1016\/s0165-0173(00)00019-9.","journal-title":"Brain Res Brain Res Rev"},{"key":"15124_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaneurol.2014.367","volume":"71","author":"P Shahim","year":"2014","unstructured":"Shahim P, Tegner Y, Wilson DH, Randall J, Skillb\u00e4ck T, Pazooki D, et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014;71:684\u201392. https:\/\/doi.org\/10.1001\/jamaneurol.2014.367.","journal-title":"JAMA Neurol"},{"key":"15124_CR15","doi-asserted-by":"publisher","unstructured":"Bailey DM, Bain AR, Hoiland RL, Barak OF, Drvis I, Hirtz C, et al. Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans. J Cereb Blood Flow Metab. 2022:271678X221075967. https:\/\/doi.org\/10.1177\/0271678X221075967.f","DOI":"10.1177\/0271678X221075967.f"},{"key":"15124_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-med-043021-032816","volume":"74","author":"E Nemeth","year":"2023","unstructured":"Nemeth E, Ganz T. Hepcidin and iron in health and disease. Annu Rev Med. 2023;74:261\u201377. https:\/\/doi.org\/10.1146\/annurev-med-043021-032816.","journal-title":"Annu Rev Med"},{"key":"15124_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12967-018-1399-5","volume":"16","author":"D Vela","year":"2018","unstructured":"Vela D. Hepcidin, an emerging and important player in brain iron homeostasis. J Transl Med. 2018;16:25. https:\/\/doi.org\/10.1186\/s12967-018-1399-5.","journal-title":"J Transl Med"},{"key":"15124_CR18","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1021\/nl060227d","volume":"6","author":"DM Rissin","year":"2006","unstructured":"Rissin DM, Walt DR. Digital concentration readout of single enzyme molecules using femtoliter arrays and Poisson statistics. Nano Lett. 2006;6:520\u20133. https:\/\/doi.org\/10.1021\/nl060227d.","journal-title":"Nano Lett"},{"key":"15124_CR19","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.3390\/ijms25126295","volume":"25","author":"Y Park","year":"2024","unstructured":"Park Y, Kc N, Paneque A, Cole PD. Tau, glial fibrillary acidic protein, and neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases. Int J Mol Sci. 2024;25:6295. https:\/\/doi.org\/10.3390\/ijms25126295.","journal-title":"Int J Mol Sci"},{"key":"15124_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.14740\/wjon1228","volume":"10","author":"A Hepner","year":"2019","unstructured":"Hepner A, Porter J, Hare F, Nasir SS, Zetterberg H, Blennow K, et al. Serum neurofilament light, glial fibrillary acidic protein and tau are possible serum biomarkers for activity of brain metastases and gliomas. World J Oncol. 2019;10:169\u201375. https:\/\/doi.org\/10.14740\/wjon1228.","journal-title":"World J Oncol"},{"key":"15124_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbi.2019.04.005","volume":"79","author":"ACA Chiang","year":"2019","unstructured":"Chiang ACA, Huo X, Kavelaars A, Heijnen CJ. Chemotherapy accelerates age-related development of tauopathy and results in loss of synaptic integrity and cognitive impairment. Brain Behav Immun. 2019;79:319\u201325. https:\/\/doi.org\/10.1016\/j.bbi.2019.04.005.","journal-title":"Brain Behav Immun"},{"key":"15124_CR22","doi-asserted-by":"publisher","first-page":"1448089","DOI":"10.3389\/fonc.2024.1448089","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Tang X, Lei T, Fu D, Zhang H. Lipocalin-2 promotes breast cancer brain metastasis by enhancing tumor invasion and modulating brain microenvironment. Front Oncol. 2024;14:1448089. https:\/\/doi.org\/10.3389\/fonc.2024.1448089.","journal-title":"Front Oncol"},{"key":"15124_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.aaz2193","volume":"369","author":"Y Chi","year":"2020","unstructured":"Chi Y, Remsik J, Kiseliovas V, Derderian C, Sener U, Alghader M, et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science. 2020;369:276\u201382. https:\/\/doi.org\/10.1126\/science.aaz2193.","journal-title":"Science"},{"issue":"5","key":"15124_CR24","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/0008-5472.CAN-10-3614","volume":"71","author":"SV Torti","year":"2011","unstructured":"Torti SV, Torti FM. Ironing out cancer. Cancer Res. 2011;71(5):1511\u20134. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3614.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15124-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15124-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:01:29Z","timestamp":1763737289000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15124-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15124"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15124-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed in accordance with the Good Clinical Practice (GCP) guidelines as defined by the International Conference on Harmonization (ICH), and the French regulations in force (i.e., the French Public Health Law N. 2004\u2013806 of August 9, 2004; Loi n. 2004- 806 du 9 ao\u00fbt 2004 relative \u00e0 la politique de sant\u00e9 publique), the Bioethical Laws, the declaration of Helsinki (Appendix 9) and the Informatics and Freedom Law. This study is registered at ClinicalTrials.gov (\n                      \n                      : Identifier NCT03252912). It was approved by the Ethics Committee (CPP SUD MEDITERRANEE 13\/07\/2016, n\u00b02016\u201305-03 bis). The patient\u2019s written informed consent was obtained before collecting any personal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"All contributing authors approve the submission and publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"- AD, SL, CH, SP, ML, NP, AA and CD declare no conflict of interest related to this study.- WJ has received fees (Astra Zeneca, Eisai, BMS, Lilly France, Daiichi Sankyo, MSD, Novartis, Pfizer, Roche, Seagen), support for attending meetings\/travel (Astra Zeneca, Novartis, Chugai Pharma, Pfizer, Eisai, Pierre Fabre, Glaxo Smithkline, Roche, Lilly France, Sanofi Aventis) and participated on a Data Safety Monitoring Board or Advisory Board (Astra Zeneca, Eisai, BMS, Lilly France, Daiichi Sankyo, MSD, Novartis, Pfizer, Roche, Seagen, Gilead).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1801"}}